Description

1-(4-(Trifluoromethyl)Phenethyl)-6,7-Dimethoxy-3,4-Dihydroisoquinoline is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly for its role as a key building block in synthesizing novel therapeutic agents. It is primarily required by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic institutions focused on developing new drug candidates, especially in areas targeting central nervous system and cardiovascular diseases.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the multi-step synthesis of potential drug candidates, particularly those with isoquinoline-based pharmacophores.
• Medicinal Chemistry Research: Used extensively in structure-activity relationship (SAR) studies and lead optimization processes within drug discovery programs.
• Chemical Biology Probes: Acts as a scaffold for developing specialized molecular probes to study enzyme function and biological pathways.
• Fine Chemical Synthesis: Employed in the custom synthesis of complex, high-value organic molecules for specialized applications.
• Academic & Institutional R&D: Utilized in university and government research laboratories for exploratory synthetic chemistry and novel compound library generation.

Basic Information

Product Name	1-(4-(Trifluoromethyl)Phenethyl)-6,7-Dimoxy-3,4-Dihydroisoquinoline
CAS No.	324076-69-9
Molecular Formula	C20H20F3NO2
Molecular Weight	363.38 g/mol
Synonyms	6,7-Dimethoxy-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-3,4-dihydroisoquinoline; 1-[2-(4-Trifluoromethylphenyl)ethyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 6,7-Dimethoxy-1-[4-(trifluoromethyl)phenethyl]-3,4-dihydroisoquinoline; 324076-69-9; 1-(4-Trifluoromethylphenethyl)-6,7-dimethoxy-3,4-dihydroisoquinoline; Tetrahydroisoquinoline derivative (CF3-substituted)
EINECS	Contact for details

Quality Control

Our 1-(4-(Trifluoromethyl)Phenethyl)-6,7-Dimethoxy-3,4-Dihydroisoquinoline is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing all specifications and test results are provided with every shipment and are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed in a dry environment to prevent any potential moisture uptake or degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.